|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R | 2012 | EN2012，，3： | 6 |
| 2 | Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus显示文摘 | Stranders I Diamant M van Gelder RE | 2004 | Arch Intern Med2004，164，： | 1 |
| 3 | One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial显示文摘 | Bunck MC Diamant M Comer A | 2009 | Diabetes Care2009，32，5： | 1 |
| 4 | Bicycle exerciseenhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, orTNF-alpha pre-mRNA in BMNC显示文摘 | ULLUM H HAAHR P M DIAMANT M | 1994 | J Appl Physiol1994，77，1： | 1 |
| 5 | Cellular microparticles:new players in the field of vascular disease?显示文摘 | Diamant M Tushuizen ME Sturk A | 2004 | Eur J Clin Invest2004，34，6： | 1 |
| 6 | Magnetic resonance assessment of aortic pulse wave velocity, aortic distensibility, and cardiac function in uncomplicated type 2 diabetes mellitus显示文摘 | Vander Meer RW Diamant M Westenberg JJ | 2007 | J Cardiovasc Magn Reson2007，9，4： | 1 |
| 7 | Alanine aminotrans- feras as a mal'ker of non-alcoholic fatty liver disease inrelation totype 2 diabetes mellitus and cardiovascular disease 显示文摘 | Schindhelm RK Diamant M Dekker JM | 2006 | Diabetes Metab Res Rev2006，22，： | 1 |
| 8 | Elevated matrix- metalloproteinase- 2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy 显示文摘 | Diamant M Hanemaaijer R Verheijen JH | 2001 | Dia- bet Med2001，18，5： | 1 |
| 9 | Cellular microparticles:new players in the field of vascular disease显示文摘 | Diamant M Tushuizen ME Sturk A | 2004 | Eur J Clin Invest2004，34，6： | 1 |
| 10 | Testis response to low doses of cadmium in Wistar rats显示文摘 | de Souza Predes P Diamante M A Dolder H | | 0，，02： | 1 |
| 11 | Myocardial insulin action and the contribution of in- sulin resistance to the pathogenesis of diabetic cardiomyopathy显示文摘 | Ouwens DM Diamant M | 2007 | Arch Phys- iol Biochem2007，113，2： | 1 |
| 12 | One-year treatment with exenatide improves beta-cell function,compared with insulin glargine,in metformin-treated type 2 diabetic patients:a randomized,controlled trial显示文摘 | Bunck M C Diamant M Corner A | 2009 | Diabetes Care2009，32，： | 1 |
| 13 | Dipeptidyl peptidase-4 in- hibitors and preservation of pancreatic islet-cell function : a criti- cal appraisal of the evidence显示文摘 | Genugten RE Raahe DH Diamant M | 2012 | Diabetes Obes Metab2012，14，2： | 1 |
| 14 | One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial 显示文摘 | BUNCK M C DIAMANT M CORNIER A | 2013 | Diabetes Care2013，32，5： | 1 |
| 15 | Admissionblood glucose level as risk indicator of death after myocardialinfarction in patients with without diabetes mellitus 显示文摘 | Stranders I Diamant M van Gelder RE | 2004 | ArchIntern Med2004，164，9： | 1 |
| 16 | Elevatedmatrix metalloproteinase-2 and-9 in urne,but not in serum,are markers of type 1 diabetic nephropathy显示文摘 | Diamant M Hanemaaijier R Verheijen JH | 2002 | Diabet Med2002，18，5： | 1 |
| 17 | Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus显示文摘 | STRANDERS I DIAMANT M VAN GELDER R E | 2004 | Arch Intern Med2004，164，： | 1 |
| 18 | Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in nonmotriglyceridaemie subjects with type 2 diabetes mellitus 显示文摘 | Schindhelm RK Diamant M Bakker SJ | 2005 | Eur J Clin Intest2005，215，： | 1 |
| 19 | Exenatide affectscirculating cardiovascular risk biomarkers independently ofchanges in body composition显示文摘 | Bunck MC Diamant M Eliasson | 2010 | Diabetes Care2010，33，8： | 1 |
| 20 | One-year treatment with exenatide improves beta-cell function, compared with insulin glagine , in metformin-treated type 2 diabetic patients: a randomized, controlled trial显示文摘 | Bunck MC Diamant M Corner A | 2009 | Diabetes Care2009，32，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员